2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 2.353.252 | 2.765.072 | 3.207.370 | 3.670.578 | 4.054.919 | 4.558.395 | 5.595.068 | 6.533.623 | 9.178.645 | 11.613.266 |
Total Income - EUR | 2.375.133 | 2.785.199 | 3.281.802 | 3.778.182 | 4.056.668 | 4.587.403 | 5.619.783 | 6.554.226 | 9.185.142 | 11.643.347 |
Total Expenses - EUR | 2.173.515 | 2.485.477 | 3.024.898 | 3.460.966 | 3.683.815 | 4.211.336 | 5.090.184 | 6.028.704 | 8.572.269 | 11.108.406 |
Gross Profit/Loss - EUR | 201.618 | 299.721 | 256.904 | 317.215 | 372.853 | 376.068 | 529.600 | 525.522 | 612.872 | 534.940 |
Net Profit/Loss - EUR | 165.095 | 259.324 | 216.412 | 254.600 | 309.475 | 313.045 | 461.033 | 456.789 | 524.578 | 449.650 |
Employees | 25 | 31 | 38 | 42 | 41 | 45 | 44 | 49 | 59 | 71 |
Check the financial reports for the company - Pharmaplus Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 570.909 | 794.063 | 792.611 | 723.784 | 858.651 | 816.693 | 784.714 | 1.103.476 | 1.113.673 | 1.809.962 |
Current Assets | 669.205 | 762.241 | 862.136 | 1.078.643 | 1.457.639 | 1.514.742 | 2.072.823 | 2.306.890 | 3.456.446 | 4.167.056 |
Inventories | 376.333 | 495.000 | 612.263 | 788.986 | 1.041.239 | 1.091.551 | 1.205.005 | 1.471.423 | 1.841.584 | 2.860.234 |
Receivables | 240.073 | 237.688 | 119.287 | 267.346 | 399.562 | 416.121 | 683.939 | 723.238 | 1.566.704 | 1.253.763 |
Cash | 52.799 | 29.553 | 130.586 | 22.311 | 16.838 | 7.070 | 183.879 | 112.229 | 48.157 | 53.058 |
Shareholders Funds | 410.300 | 596.558 | 439.469 | 686.632 | 725.636 | 856.044 | 1.056.901 | 808.948 | 596.504 | 729.032 |
Social Capital | 22.311 | 22.497 | 22.268 | 21.891 | 21.489 | 21.073 | 20.674 | 20.215 | 20.278 | 222.379 |
Debts | 830.870 | 959.496 | 1.217.605 | 1.118.907 | 1.591.917 | 1.480.563 | 1.807.009 | 2.609.590 | 3.984.850 | 5.245.657 |
Income in Advance | 2.247 | 1.802 | 1.326 | 853 | 395 | 0 | 0 | 0 | 0 | 10.628 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Pharmaplus Srl